165-171. DOI: 10.1080165-171. DOI: 10. /2000656X.2016 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.• You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. In a retrospective observational study, we evaluated outcome after open carpal tunnel release focusing on factors related to the metabolic syndrome: diabetes, hypertension, obesity (BMI ≥ 30) and statin treatment.
MethodsResults from 493 out of 962 patients (531/1044 hands) operated for CTS during 18 months that had filled in QuickDASH questionnaires before and one year after surgery were included in the study.
ResultsPatients with diabetes (n=76) p<0.05). The odds of having a change in QuickDASH score <8 was 2.6 times higher in patients with polyneuropathy than in patients without polyneuropathy.Patients with hypertension, obesity or statin treatment had a similar improvement after surgery as patients without these factors.
ConclusionsPatients with diabetes without neuropathy, as well as patients with hypertension, obesity or statin treatment, and CTS can expect the same effects of open carpal tunnel release as otherwise healthy patients. Patients with diabetic neuropathy and CTS did not experience the 3 same improvement as otherwise healthy patients and should be informed about the risk of an unsatisfactory outcome.Word count abstract: 242